ResearcherNo recent work listed

Sampanna Jung Rayamajhi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8383-3216; OpenAlex author ID A5007375525. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper

Papers 1

Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma. Co-author DOI 10.1007/s00261-017-1316-z ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Matthew H. G. Katz · 1 shared paper, 2018 · strength 0.10
- Paper Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcino… DOI 10.1007/s00261-017-1316-z ↗
Aparna Balachandran · 1 shared paper, 2018 · strength 0.10
- Paper Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcino… DOI 10.1007/s00261-017-1316-z ↗
Priya Bhosale · 1 shared paper, 2018 · strength 0.10
- Paper Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcino… DOI 10.1007/s00261-017-1316-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.